The CapOpus Trial: Specialized Treatment for Cannabis Abuse in Young Patients with Psychosis
Author Information
Author(s): Hjorthøj Carsten, Fohlmann Allan, Larsen Anne-Mette, Madsen Mette TR, Vesterager Lone, Gluud Christian, Arendt Mikkel C, Nordentoft Merete
Primary Institution: Psychiatric Center Bispebjerg, Faculty of Health Sciences, Copenhagen University
Hypothesis
Does a specialized addiction treatment program improve outcomes for young patients with cannabis abuse and psychosis compared to treatment as usual?
Conclusion
The CapOpus trial aims to evaluate the effectiveness of a specialized treatment program for cannabis abuse among young patients with psychosis.
Supporting Evidence
- Previous studies indicate a link between cannabis use and psychosis.
- Effective interventions to limit cannabis use in persons with psychosis are needed.
- Motivational interviewing has shown positive effects in previous trials.
Takeaway
This study is trying to find out if a special treatment for young people who use cannabis and have psychosis can help them more than regular treatment.
Methodology
A randomized, parallel-group, observer-blinded clinical trial comparing specialized addiction treatment with treatment as usual over six months.
Potential Biases
There is a risk of selection and allocation bias due to the nature of the treatment assignment.
Limitations
The trial may have a small sample size and the control treatment is not uniform, which could introduce bias.
Participant Demographics
Young patients aged 18-35 with cannabis abuse and psychosis, primarily recruited from community mental health centers.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website